Patent details

300518 Product Name: Telaprevir, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout en/of solvaat daarvan, of solvaten van dergelijke zouten.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300518
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1320540
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300518
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

1

Marketing Authorization Number:
EU/1/11/720/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/09/2011
Marketing Authorization Country:
European Union (EU)

2

Marketing Authorization Number:
EU/1/11/720/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/09/2011
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
19/03/2012
First Marketing Authorization date:
19/09/2011
Grant date:
30/08/2012
Activation date:
31/08/2021
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
19/03/2012
SPC/SPC Extension Expiration Date:
30/08/2026
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
19/03/2012
 
 

 

Name:
Vertex Pharmaceuticals Incorporated
Address:
130 Waverly Street, 02139, CAMBRIDGE, MASSACHUSETTS, United States of America (US)

Agent

Name:
ir. C.M. Jansen c.s.
From:
19/03/2012
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
15/18
Publication date:
04/04/2018
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
2012/36
Publication date:
05/09/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2012/13
Publication date:
28/03/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/08/2021
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
30/08/2012 Outgoing Correspondence Outgoing Letter 1 PDF /8/1/5/0/0/0400300518/docs/300518_0_outgoingcorrespondence20120830.pdf
30/08/2012 Outgoing Correspondence Outgoing Letter 1 PDF /8/1/5/0/0/0400300518/docs/300518_5_outgoingcorrespondence20120830.pdf
27/08/2012 General 1 PDF /8/1/5/0/0/0400300518/docs/300518_10_spc-documents20120827.pdf
24/07/2012 Incoming Correspondence Paper Other 2 PDF /8/1/5/0/0/0400300518/docs/300518_3_incomingcorrespondencepaper20120724.pdf
24/04/2012 Outgoing Correspondence Outgoing Letter 2 PDF /8/1/5/0/0/0400300518/docs/300518_2_outgoingcorrespondence20120424.pdf
24/04/2012 Outgoing Correspondence Outgoing Letter 2 PDF /8/1/5/0/0/0400300518/docs/300518_4_outgoingcorrespondence20120424.pdf
20/03/2012 Outgoing Correspondence Outgoing Letter 1 PDF /8/1/5/0/0/0400300518/docs/300518_6_outgoingcorrespondence20120320.pdf
19/03/2012 General 1 PDF /8/1/5/0/0/0400300518/docs/300518_1_spc-documents20120319.pdf
19/03/2012 Application Form First filed application form 2 PDF /8/1/5/0/0/0400300518/docs/300518_7_applicationform20120319.pdf
19/03/2012 General 32 PDF /8/1/5/0/0/0400300518/docs/300518_8_spc-documents20120319.pdf
19/03/2012 General 5 PDF /8/1/5/0/0/0400300518/docs/300518_9_spc-documents20120319.pdf